Dicot Pharma AB (STO:DICOT)
Sweden · Delayed Price · Currency is SEK 0.5340
+0.0070 (1.33%)
At close: Oct 31, 2025
Dicot Pharma AB Company Description
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden.
It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024.
Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Dicot Pharma AB
| Country | Sweden |
| Founded | 2015 |
| Industry | Pharmaceutical Preparations |
| Employees | 3 |
| CEO | Elin Trampe |
Contact Details
Address: S:t Olofsgatan 11A Uppsala, 753 21 Sweden | |
| Phone | 46 7 25 02 10 10 |
| Website | dicotpharma.com |
Stock Details
| Ticker Symbol | DICOT |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Elin Trampe | Chief Executive Officer |
| Dr. Jarl Wikberg Ph.D. | Founder |
| Bjorn Petersson | Chief Financial Officer |
| Dr. Mats Silvander Ph.D. | Chief Technical Officer |
| Charlotta Gauffin | Chief Scientific Officer |
| Hakan Wickholm | Chief Business Officer |